Brain alteration of PCOS: neuroimaging and function - Report - MDSpire

Brain alteration of PCOS: neuroimaging and function

  • By

  • Ningxiao Jiang

  • Jie Deng

  • Changjin Bao

  • Hongmei Yin

  • Xianghui Zhang

  • Yanxia Ding

  • Shinan Zhang

  • Yingjiang Xu

  • Xinghua Diao

  • Kexin Lu

  • Jun Liu

  • Lei Han

  • June 11, 2026

  • 0 min

Share

Clinical Report: Neuroimaging and Functional Changes in PCOS

Overview

This review highlights significant neuroimaging alterations in women with polycystic ovary syndrome (PCOS), including pituitary gland enlargement and reduced gray matter volume. These changes are linked to metabolic dysregulation and cognitive-emotional disturbances, underscoring the need for further research into the pathophysiology of PCOS.

Background

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by various metabolic and reproductive dysfunctions. Understanding the neurobiological underpinnings of PCOS is crucial, as it may inform diagnostic and therapeutic strategies. Recent studies suggest that brain structural and functional changes may contribute to the clinical manifestations of PCOS, including emotional and cognitive symptoms.

Data Highlights

No specific numerical data or trial data provided in the article.

Key Findings

  • Enlargement of the pituitary gland observed in PCOS patients.
  • Reduction in gray matter volume linked to PCOS.
  • Damage to the corpus callosum identified in neuroimaging studies.
  • Altered μ-opioid receptor binding capacity in emotion-related brain regions.
  • Changes in activity within the right orbitofrontal cortex associated with sympathetic activation.
  • Structural and functional brain alterations correlated with abnormal glucose metabolism and disordered eating behaviors.

Clinical Implications

Healthcare professionals should consider the neurobiological aspects of PCOS when evaluating and treating patients. Recognizing the potential for cognitive and emotional disturbances may lead to more comprehensive management strategies, including mental health support and tailored interventions.

Conclusion

The neuroimaging findings in PCOS provide valuable insights into the disorder's pathophysiology, highlighting the interplay between endocrine, metabolic, and neurobiological factors. Further research is essential to clarify these relationships and enhance clinical outcomes.

Related Resources & Content

  1. Cureus, 2023 -- Retinal Changes Linked to PCOS
  2. BMC Medical Informatics and Decision Making, 2023 -- AI models may improve PCOS detection
  3. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Cytokine Profiling Across Diverse Populations Indicates Immune Dysregulation Rather Than Chronic Inflammation in Polycystic Ovary Syndrome
  4. Frontiers in Endocrinology, 2026 -- IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS
  5. 2023 Evidence-Based Guidelines for PCOS
  6. Neurology, 2024 -- Associations of Polycystic Ovary Syndrome With Indicators of Brain Health at Midlife in the CARDIA Cohort
  7. https://www.tjod.org/wp-content/uploads/2025/01/Evidence-Based-Guidelines-PCOS-2023.pdf
  8. Associations of Polycystic Ovary Syndrome With Indicators of Brain Health at Midlife in the CARDIA Cohort | Neurology

Original Source(s)

Related Content